Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients

Nephron - Clinical Practice

Volumn 117, Issue 4, 2011, Pages

  Kurnatowska, Ilona ^a   Grzelak, Piotr ^a   Kaczmarska, Magdalena ^a   Stefańczyk, Ludomir ^a   Nowicki, Michał ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hemodialysis; Intima media thickness; Osteoprotegerin; Vascular calcification

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; LIPID; OSTEOPROTEGERIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CLINICAL ARTICLE; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CALCINOSIS; COHORT STUDIES; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 77956796386     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321169     Document Type: Article

References (41)

1. Foley RN: Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischaemic heart disease, and cardiac failure. Semin Dial 2003; 16: 111-117.
2. Jang HH, Kim SW, Han H: Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 2006; 21: 1915-1920.
3. Drüeke TB: Arterial intima media calcification: distinct entities with different pathogenesis of all the same? Clin J Am Soc Nephrol 2008; 3: 1583-1584.
4. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H: Arterial media calcification and end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
5. Kurnatowska I, Grzelak P, Stefańczyk L, Nowicki M: Tight relations between coronary calcifications and atherosclerotic lesions in the carotid artery in chronic dialysis patients. Nephrology 2010; 15: 184-189.
6. Huybrechts KF, Caro JJ, London GM: Modeling the implications of changes in vascular calcification in patients on haemodialysis. Kidney Int 2005; 65: 1532-1538. (Pubitemid 40463132)
7. Nishizawa Y, Shoji T, Maekawa K, Nagasue K, Okuno S, Kim M, Emoto M, Ishimura E, Nakatani T, Miki T, Inaba M: Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2003; 41:S76-S79. (Pubitemid 36278351)
8. Stompór T, Kraśniak A, Sułowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tabor B, Kowalczyk-Michałek ME, Zdzienicka A, Janusz-Grzybowska E: Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant 2005; 20: 404-412. (Pubitemid 40276899)
9. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult haemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701.
10. Moe SM, O'Neill KD, Resterova M, Fineberg N, Persohn S, Meyer CA: Natural history of vascular calcifications in dialysis and transplant patients. Nephrol Dial Transplant 2004; 19: 2387-2393. (Pubitemid 39214138)
11. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824. (Pubitemid 43169927)
12. Tintut Y, Demer LL: Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 2001; 12: 555-560. (Pubitemid 32980305)
13. Collin-Osdoby P: Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004; 95: 1046-1057.
14. Khosla S: Minireview: the OPG/RANK-L/ RANK system. Endocrinology 2001; 142: 5050-5055.
15. Nybo M, Rasmussen LM: The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systemic literature review. Eur J Endocrinol 2008; 159: 603-608.
16. Mesquita M, Demulder A, Damry N, Mélot C, Wittersheim E, Willems D, Dratwa M, Bergmann P: Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clin Chem Lab Med 2009; 47: 339-346.
17. Cozzolino M, Dusso AS, Slatopolsky E: Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 2001; 12: 2511-2516. (Pubitemid 33021131)
18. Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N: Vascular Calcification Work Group. Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004; 43: 572-579. (Pubitemid 38298218)
19. Mirza MA, Hansen T, Johansson L, Ahlström H, Larsson A, Lind L, Larsson TE: Relationship between circulating FGF 23 and total body atherosclerosis in the community. Nephrol Dial Transplant 2009; 24: 3125-3131.
20. Bellasi A, Ferramosca E, Munter P, Ratti C, Wildman RP, Block GA, Raggi P: Correlation of simple imaging test and coronary artery calcium measured by computer tomography in hemodialysis patients. Kidney Int 2006; 70: 1623-1628. (Pubitemid 44606998)
21. Aminbakhsh A, Mancini GB: Carotid intima media thickness measurements. What defines an abnormality? A systemic review. Clin Invest Med 1999; 22: 149-157.
22. Papagianni A, Kalovoulos M, Kirmizis D Vainas A, Belechri AM, Alexopoulos E, Menimos D: Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 113-119. (Pubitemid 36104486)
23. Kraśniak A, Drożdż M, Pasowicz M, Chmiel G, Michałek M, Szumilak D, Podolec P, Klimeczek P, Konieczyńska M, Wicher-Muniak E, Tracz W, Khoa TN, Souberbielle JC, Drueke TB, Sułowicz W: Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 2007; 22: 515-521.
24. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483. (Pubitemid 30318271)
25. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105. (Pubitemid 34747448)
26. Bellasi A, Raggi P: Diagnostic and prognostic value of coronary artery calcium screening. Curr Opin Cardiol 2005; 20: 375-380. (Pubitemid 41192153)
27. Ammirati AL, Dalboni MD, Cendoroglo M, Draibe SA, Santos RD, Miname M, Canziani ME: The progression and impact of vascular calcification in peritoneal dialysis. Perit Dial Int 2007; 27: 340-346. (Pubitemid 47054616)
28. Sigrist MK, Taal MW, Bungay P, McIntyre CW: Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1241-1248.
29. Shemesh J, Koren-Morag N, Apter S, Rozenman J, Kirwan BA, Itzchak Y, Motro M: Accelerated progression of coronary calcification: four-year follow-up in patients with stable coronary artery disease. Radiology 2004; 233: 201-209. (Pubitemid 39280975)
30. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268. (Pubitemid 28213402)
31. Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J: Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 2004; 109: 2175-2180. (Pubitemid 38625393)
32. Ishiyama M, Suzuki E, Katsuda J, Murase H, Tajima Y, Horikawa Y, Goto S, Fujita T, Takeda J: Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetes patients. Diabetes Res Clin Pract 2009; 85: 189-196.
33. Schlieper G, Brandenburg V, Djuric Z, Damjanovic T, Markovic N, Westenfeld R, Dimkovic N, Ketteler M, Floege J: Is there a correlation between C-reactive protein and skeletal calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients? Dtsch Med Wochenschr 2007; 132: 1820-1824.
34. Matsubara K, Stenvinkel P, Qureshi AR, Carrero JJ, Axelsson J, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Suliman ME: Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. J Nephrol 2009; 22: 774-782.
35. Morena M, Terrier N, Jaussent I, Leray-Moragues H, Chalabi L, Rivory JP, Maurice F, Delcourt C, Cristol JP, Canaud B, Dupuy AM: Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol 2006; 17: 262-270.
36. Memon F, El-Abbadi M, Nakatani T, Taguchi T, Lanske B, Razzaque MS: Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral metabolism. Kidney Int 2008; 74: 566-570.
37. Razzaque MS, St-Arnaud R, Taguchi T, Lanske B: FGF-23, vitamin D and calcification: the unholy triad. Nephrol Dial Transplant 2005; 20: 2032-2035. (Pubitemid 41510074)
38. Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M: Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 2004; 44: 250-256. (Pubitemid 38962552)
39. Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T, Ishimura E, Nishizawa Y: Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic haemodialysis patients. Osteoporos Int 2006; 17: 1506-1513. (Pubitemid 44387485)
40. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C: Peripheral vascular calcification in long haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant 2009; 24: 948-955.
41. Kojima F, Uchida K, Ogawa T, Tanaka Y, Nitta K: Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients an chronic haemodialysis. Int Urol Nephrol 2008; 40: 1067-1074.